About SynDevRx
Management Team

The SynDevRx executive team has established an efficient system for quickly and productively advancing drugs through the FDA regulatory process.

Founders

Bradley J Carver, co-Founder, President and CEO

Throughout Brad's 13 year history as a biotech leader, Brad repeatedly created value for his investors.  In less than 5 years, he increased the value of his publicly traded company GlycoGenesys (Russell 2000 and NASDAQ listed) from $25M to well over $500M.  He successfully completed a partnership deal with Elan Pharmaceuticals, and developed and put into clinical trials one of the world's first complex carbohydrate cancer drug candidates GCS100, which continues in clinical trials as a promising drug candidate.

Brad’s thoughtful execution, resourcefulness and team building skills allowed the company to solve extremely complex manufacturing and characterization issues, identify and characterize multiple mechanisms of action for GCS-100 that, previous to his work, were not thought possible for a naturally derived complex carbohydrate.   He led the clinical trial program design effort and was key in selecting the target indications.

Brad attended Michigan State University, where he received his BA in Business.

James M Shanahan, co-Founder, VP Business Development

Jim was founder and VP Marketing of his most recent company - JAM Technologies, Inc., where he successfully licensed the company's novel technology to AKM Japan, and was instrumental in forming a strategic co-development partnership with Intel.  Jim also built the company's sales and distribution channels in Asia, plus established the compnay's market positioning with industry leaders including Bose, Apple Computer, Dell, National Semiconductor, and SRS among others.  He also was responsible for establishing sales opportunities with major OEMs in Japan, Taiwan, China and Korea.

Jim ran all aspects of the company's operations for the first 5 years, including financing, legal, licensing, IP, and strategic planning. Jim has two pending patent applications from his work at JAM.

Jim attended the University of Massachusetts at Amherst and L'Universite Catholique, Angers France, where he received his Diplôme Supérieur.

 

Key Management and Consultants

Watch here for upcoming announcements on key management.